Updated Jul 16, 2026
Yablonka Uri has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Yablonka Uri is an executive at BrainStorm Cell Therapeutics Inc., with SEC filings identifying him as EVP and Chief Business Officer as of the 2026 filing period. In this role, he is responsible for guiding corporate strategy, leading business development initiatives, and overseeing external financing activities, investor relations, and strategic partnerships critical to BrainStorm’s stem cell therapy programs for neurodegenerative diseases.
| Role | EVP & Chief Business Officer, Director |
|---|---|
| Notability | 45/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-29 | BCLI | BRAINSTORM CELL THERAPEUTICS INC. | A — Grant or award | 150.0K | $0.00 |
Yablonka Uri is an executive at BrainStorm Cell Therapeutics Inc., with SEC filings identifying him as EVP and Chief Business Officer as of the 2026 filing period. In this role, he is responsible for guiding corporate strategy, leading business development initiatives, and overseeing external financing activities, investor relations, and strategic partnerships critical to Brain…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Yablonka Uri profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.